Pfizer Chief Executive Albert Bourla said on Tuesday he expects a “very intense” meeting with a U.S. vaccine advisory panel this week but is counting on the outside experts to sign off on his company’s COVID-19 vaccine candidate.
The U.S. Centers for Disease Control and Prevention (CDC) on Tuesday alerted clinicians about risks of counterfeit versions of AbbVie’s Botox that were given to…
Laboratory operator Quest Diagnostics raised its 2024 profit and revenue forecast on Tuesday after beating first-quarter estimates on robust demand for its diagnostic tests.
Pfizer and BioNTech asked a London court to revoke rival Moderna’s patents over technology key to the development of vaccines for COVID-19, as the latest…
Danaher beat quarterly profit and sales expectations on Tuesday, driven by strength in its diagnostics and bioprocessing businesses, sending shares of the life sciences firm…
Nine months into the U.S. launch of the first drug proven to slow the advance of Alzheimer’s, Eisai and Biogen’s Leqembi is facing an unexpected…
The U.S. Centers for Disease Control and Prevention (CDC) on Tuesday alerted clinicians about risks of counterfeit versions of AbbVie’s Botox that were given to…
Laboratory operator Quest Diagnostics raised its 2024 profit and revenue forecast on Tuesday after beating first-quarter estimates on robust demand for its diagnostic tests.
Pfizer and BioNTech asked a London court to revoke rival Moderna’s patents over technology key to the development of vaccines for COVID-19, as the latest…
Danaher beat quarterly profit and sales expectations on Tuesday, driven by strength in its diagnostics and bioprocessing businesses, sending shares of the life sciences firm…
Nine months into the U.S. launch of the first drug proven to slow the advance of Alzheimer’s, Eisai and Biogen’s Leqembi is facing an unexpected…
